Similar promotion of Abeta1-42 fibrillogenesis by native apolipoprotein E epsilon3 and epsilon4 isoforms.

Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.

Emerging prospects for the disease-modifying treatment of Alzheimer's disease.

Multiple ligand binding sites on A beta(1-40) fibrils.

Inducible proteopathies.

Small molecule inhibitors of Abeta assembly.

Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity?

Molecular polymorphism of Abeta in Alzheimer's disease.

The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors.

The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors.

[Anonymous].  2009.  The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors.. Bioorganic & medicinal chemistry letters. 19(3):654-7.

PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.